But, and this matters, those averages include people at both extremes
Adame L, Behrens C, Bernatchez C, Bhatta A, Bogatenkova E, Bristow CA, Bers, LA, Carter B, Carugo A, Cascone T, Celestino M, Cupian AM, Ce D, Fang B, Fayle S, Feerico L, Forget MA, Fujimoto J, Garcia-Prieto C, Gaudreau PO, Giana M, Gibbons DL, Haymaker C, Heymach JV, Hofstetter WL, Karpinets TV, Kim YU, Kovacs JJ, Landry LCA, Lawson PM, Lizee G, Majidi M, Marszalek J, Mendoza G, Meraz IM, Moghaddam S, Morgan MB, Para cuentas ER, Prado EA, Pritchard LK, Ravelli A, Reuben A, Roarty EB, Roszik J, Roth JA, Sanchez Espiridion B, Sepesi B, Sing Heir J, Swisher SG , Talukder A, Toniatti C, Tran HT, Aa V, Vasquez ME, Wagner HE, Wang L, Weissferdt A, William Jr WN, Wistuba II, Yee C, Zhang J, Zhang R, Zhang X

Adjusted population analysis finds tirzepatide more effective than semaglutide for weight loss Truveta Research then used multiple rigorous methods (including propensity score matching) to achieve a well-balanced analytic cohort of 18,000 patients to appropriately evaluate the effectiveness of semaglutide compared with tirzepatide for weight loss
1 Adolescents with obesity face an 89% likelihood of persistent obesity as adults and an increased risk for type 2 diabetes, hypertension, hyperlipidemia, MASLD, obstructive sleep apnea, anxiety, depression, social isolation, and peer victimization